These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 26202831)

  • 1. Hypothesis-based weight-of-evidence evaluation and risk assessment for naphthalene carcinogenesis.
    Bailey LA; Nascarella MA; Kerper LE; Rhomberg LR
    Crit Rev Toxicol; 2016; 46(1):1-42. PubMed ID: 26202831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naphthalene metabolism in relation to target tissue anatomy, physiology, cytotoxicity and tumorigenic mechanism of action.
    Bogen KT; Benson JM; Yost GS; Morris JB; Dahl AR; Clewell HJ; Krishnan K; Omiecinski CJ
    Regul Toxicol Pharmacol; 2008 Jul; 51(2 Suppl):S27-36. PubMed ID: 18191315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
    Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
    Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incorporating ToxCastâ„¢ data into naphthalene human health risk assessment.
    Bailey LA; Rhomberg LR
    Toxicol In Vitro; 2020 Sep; 67():104913. PubMed ID: 32526344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicity and metabolism of methylnaphthalenes: comparison with naphthalene and 1-nitronaphthalene.
    Lin CY; Wheelock AM; Morin D; Baldwin RM; Lee MG; Taff A; Plopper C; Buckpitt A; Rohde A
    Toxicology; 2009 Jun; 260(1-3):16-27. PubMed ID: 19464565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicology and carcinogenesis studies of naphthalene (cas no. 91-20-3) in F344/N rats (inhalation studies).
    Natl Toxicol Program Tech Rep Ser; 2000 Dec; (500):1-173. PubMed ID: 11725561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary evaluation of the human relevance of respiratory tumors observed in rodents exposed to naphthalene.
    Piccirillo VJ; Bird MG; Lewis RJ; Bover WJ
    Regul Toxicol Pharmacol; 2012 Apr; 62(3):433-40. PubMed ID: 22342949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the mode of action for hexavalent chromium-induced lung cancer following inhalation exposures.
    Proctor DM; Suh M; Campleman SL; Thompson CM
    Toxicology; 2014 Nov; 325():160-79. PubMed ID: 25174529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxicity of naphthalene toward cells from target and non-target organs in vitro.
    Kedderis GL; Shepard KG; Recio L
    Chem Biol Interact; 2014 Feb; 209():85-95. PubMed ID: 24361489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An adjustment factor for mode-of-action uncertainty with dual-mode carcinogens: the case of naphthalene-induced nasal tumors in rats.
    Bogen KT
    Risk Anal; 2008 Aug; 28(4):1033-51. PubMed ID: 18564993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weight of evidence analysis of the tumorigenic potential of 1,3-dichloropropene supports a threshold-based risk assessment.
    Yan ZJ; Bartels M; Gollapudi B; Driver J; Himmelstein M; Gehen S; Juberg D; van Wesenbeeck I; Terry C; Rasoulpour R
    Crit Rev Toxicol; 2020 Nov; 50(10):836-860. PubMed ID: 33528302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formaldehyde and glutaraldehyde and nasal cytotoxicity: case study within the context of the 2006 IPCS Human Framework for the Analysis of a cancer mode of action for humans.
    McGregor D; Bolt H; Cogliano V; Richter-Reichhelm HB
    Crit Rev Toxicol; 2006; 36(10):821-35. PubMed ID: 17118731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic toxicity of naphthalene: a review.
    Schreiner CA
    J Toxicol Environ Health B Crit Rev; 2003; 6(2):161-83. PubMed ID: 12554433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mode of action assessment for propylene dichloride as a human carcinogen.
    Kozal JS; Lynch HN; Klapacz J; Schoeny RS; Jean PA; Maier A
    Chem Biol Interact; 2023 Sep; 382():110382. PubMed ID: 36754223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional responses in the rat nasal epithelium following subchronic inhalation of naphthalene vapor.
    Clewell HJ; Efremenko A; Campbell JL; Dodd DE; Thomas RS
    Toxicol Appl Pharmacol; 2014 Oct; 280(1):78-85. PubMed ID: 24976557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutathione depletion is a major determinant of inhaled naphthalene respiratory toxicity and naphthalene metabolism in mice.
    Phimister AJ; Lee MG; Morin D; Buckpitt AR; Plopper CG
    Toxicol Sci; 2004 Nov; 82(1):268-78. PubMed ID: 15319489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of whole animal bioassays of the carcinogenic potential of naphthalene.
    North DW; Abdo KM; Benson JM; Dahl AR; Morris JB; Renne R; Witschi H
    Regul Toxicol Pharmacol; 2008 Jul; 51(2 Suppl):S6-14. PubMed ID: 18364246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naphthalene animal carcinogenicity and human relevancy: overview of industries with naphthalene-containing streams.
    Jeffrey Lewis R
    Regul Toxicol Pharmacol; 2012 Feb; 62(1):131-7. PubMed ID: 22197623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse specific lung tumors from CYP2F2-mediated cytotoxic metabolism: an endpoint/toxic response where data from multiple chemicals converge to support a mode of action.
    Cruzan G; Bus J; Banton M; Gingell R; Carlson G
    Regul Toxicol Pharmacol; 2009 Nov; 55(2):205-18. PubMed ID: 19589367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypothesis-based weight of evidence: a tool for evaluating and communicating uncertainties and inconsistencies in the large body of evidence in proposing a carcinogenic mode of action--naphthalene as an example.
    Rhomberg LR; Bailey LA; Goodman JE
    Crit Rev Toxicol; 2010 Sep; 40(8):671-96. PubMed ID: 20722583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.